Atara Biotherapeutics, Inc. (ATRA)
17.14
+2.20
(+14.73%)
USD |
NASDAQ |
Jan 08, 12:42
Atara Biotherapeutics Market Cap: 123.58M for Jan. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pacira Biosciences, Inc. | 1.128B |
| ADMA Biologics, Inc. | 4.374B |
| NovaBay Pharmaceuticals, Inc. | 1.048B |
| Palatin Technologies, Inc. | 16.27M |
| Theriva Biologics, Inc. | 7.564M |
Market Cap Related Metrics
| PE Ratio | 7.819 |
| PS Ratio | 1.337 |
| Price | 17.14 |
| Earnings Yield | 12.79% |
| Operating PE Ratio | 5.406 |
| Normalized PE Ratio | 5.884 |